This study, based on 667 patients with papillary thyroid carcinoma (PTC), integrated BRAF V600E mutation abundance with clinical data and developed multiple machine learning models to predict the risk of cervical lymph node metastasis (CLNM). Here, BRAF is linked to differentiated thyroid carcinoma.